57825-29-3

Basic information

• Product Name: Benzene, 1-(bromomethyl)-2-ethyl-
• CAS NO: 57825-29-3
• Molecular Formula: C9H11Br
• Molecular Weight: 199.09
• Mol File: 57825-29-3.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Benzene, 1-(bromomethyl)-2-ethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 1-(bromomethyl)-2-ethyl-(57825-29-3)
• EPA Substance Registry System: Benzene, 1-(bromomethyl)-2-ethyl-(57825-29-3)

Safety Data

• Hazardous Substances Data: 57825-29-3(Hazardous Substances Data)

Upstream product

• 50-00-0 formaldehyd 
• 100-41-4 ethylbenzene 
• 10035-10-6 hydrogen bromide 
• 612-19-1 2-ethylbenzoic acid 
• 40391-19-3 (1R*,1'RS*)-1-cyclohex-2-enylethanol 
• 22927-13-5 2-ethylbenzaldehyde 
• 89-95-2 2-methyl-benzyl alcohol 
• 506-68-3 bromocyane 
• 767-90-8 (2-ethylphenyl)methanol 
• 871887-29-5 4-(2-ethylbenzyl)morpholine 

Downstream Products

• 74533-20-3 2-(2-ethylphenyl)acetonitrile 
• 1257335-34-4 (E)-3-(1-(2-ethylbenzyl)-2-oxo-1, 2-dihydropyridin-3-yl)-N-hydroxyacrylamide 
• 1400902-37-5 (E)-2-(2-ethylbenzyl)-3-oxo-3-(4-phenylcyclohexyl)-propionic acid ethyl ester 
• 911405-99-7 C₂₆H₃₅N₃O₃ 
• 1001096-01-0 C₂₄H₃₀NO₄P 
• 5553-49-1 N-(2-Ethyl-benzyl)-N-(2-ethyl-benzyloxy)-carbamidsaeure-ethylester 
• 15255-92-2 N-(2-Ethyl-benzyloxy)-carbamidsaeure-ethylester 

Relevant articles and documents

ALKOXYBENZO-FIVE-MEMBERED (SIX-MEMBERED) HETEROCYCLIC AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF

The invention relates to alkoxybenzeno five- or six-member heterocyclic amines compounds as scheme I , in which the R1, R2 and R3 are consistent with the detailed description in the patent claim. The compounds can act as selective sphingomyelin synthase 2 (SMS2) inhibitors to treat diseases caused by abnormal increasing of sphingomyelin (SM). This invention also includes compounds as scheme I , including pharmaceutically acceptable salts, pharmaceutical compositions as the active ingredients, and their application in drugs which can prevent and cure diseases caused by abnormal increasing of SM. These diseases caused by abnormal increasing of SM include atherosclerosis, type II diabetes, fatty liver, obesity, metabolic syndromes, enteritis and other inflammatory diseases.

Propionic Acid Derivatives and Methods of Use Thereof

Provided herein are compounds and pharmaceutical compositions of formula I where R1, R2, R3, R4, R5, X and R6 are as described herein. Also provided pharmaceutically acceptable salts or stereoisomer(s) of these compounds. In addition methods are provided for antagonizing the action of an α4-integrin to treat various pathophysiological conditions.

ANTIVIRAL PHOSPHINATE COMPOUNDS

The invention is related to anti-viral phosphinate compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.